
During perimenopause, women are more likely to experience symptoms of depression, and during postmenopause, they are more likely to experience anxiety symptoms.

During perimenopause, women are more likely to experience symptoms of depression, and during postmenopause, they are more likely to experience anxiety symptoms.

Physician burnout and stress have grown rampant across the world of medicine. What are some of the practices doctors, universities, and health care leaders use to fight them?

This is the first study to compare WET directly with another PTSD treatment.

The findings have important implications for transforming the way mental health care is delivered in primary care settings.

No significant differences were found between the non-impaired participants and the AD group regarding personality changes prior to onset.

Caffeine may have a role to play in both future Parkinson's disease diagnosis and prevention.

A large cohort study finds taking acetaminophen for 29 days or more during pregnancy doubles risk of ADHD in offspring.

The rare disease is caused by the mutation of one of the top risk genes for autism spectrum disorder.

A new study suggests the novel therapy can help empower patients with psychoses.

Risks increase when a child’s mother, versus their father has a history of homelessness.

The first-of-its-kind prescription digital medicine video game plans for regulatory filing in the first half of 2018.

Reddit's Ask Me Anything forums have proven to give physicians a chance to connect with and educate thousands of people at once.

Greater reductions in brain glycolysis demonstrated a relationship to symptoms of Alzheimer’s disease like memory problems.

In all cases of participants experiencing housing problems for even 1 year, indicated poorer mental health.

Two phase 3 clinical trials begin enrollment for treatment of manic episodes associated with bipolar I disorder.

Positive results showed 6 weeks of treatment associated with significant improvement of depressive symptoms in children and adolescents.

ARISTADA is being investigated as a possible extended-release injectable suspension, as well as INVEGA SUSTENNA in patients with acute exacerbation of schizophrenia.

Socioeconomic factors may play the largest role in increased suicide rates as they vary by urbanization level.

Evening-dosed psychostimulant is the first long-acting MPH single-dose formulation to show improvements in at-home early morning functional impairment.

The drug is being tested for the first time on a large scale adult patient population.

In response to patient concerns about dosing options and duration of effect, researchers at Shire Pharmaceuticals created Mydayis for the treatment of ADHD symptoms.

Alnylam Therapeutics expects to file for a New Drug Application in late 2017.

Psychedelics like psilocybin have been receiving attention from psychiatrists on and off for decades. Here's what we've learned, and what's on the horizon.

Parental rejection, abandonment, physical and sexual abuse double the victim's rates of depression, inflammation, metabolic disorders and chronic medical illnesses.

Patients struggling with addiction can be difficult to treat. Following best practices can help simplify a complex process.